Arcutis Biotherapeutics Inc (ARQT)
Cost of Revenue
$10.94M
Quarterly · Period ending: · USD
ARQT Cost of Revenue
Latest reported$10.94Mperiod ending
Latest reported$10.94Mperiod ending
ARQT Quarterly Cost of Revenue ($0.00 → $10.94M)
Quarterly cost of revenue
High-resolution chart · PNG
ARQT cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 10,939,000 | |
| 9,784,000 | |
| 11,688,000 | |
| 8,685,000 | |
| 7,492,000 | |
| 8,830,000 | |
| 6,905,000 | |
| 5,503,000 | |
| 3,464,000 | |
| 3,256,000 | |
| 2,246,000 | |
| 1,182,000 | |
| 776,000 | |
| 783,000 | |
| 485,000 | |
| 269,000 | |
| 234,000 | |
| 229,000 | |
| 211,000 | |
| 192,000 | |
| 182,000 | |
| 178,000 | |
| 166,000 | |
| 0 | |
| 57,000 | |
| 65,000 | |
| 60,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |